Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs and Organics has submitted a quarterly compliance certificate under SEBI's Regulation 74(5) for the period ending June 30, 2025. The certificate was issued by MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent, confirming that all dematerialisation requests received during the quarter were properly processed and reflected with the depositories. Importantly, the filing notes that no requests for dematerialisation were received from shareholders during the quarter. The certificate has been forwarded to both BSE and NSE for record purposes.
This is a routine regulatory compliance filing with no material impact on the company's operations, financials, or stock price. It is a standard quarterly obligation confirming the orderly handling of share dematerialisation activities.